FORT LAUDERDALE, Fla., Dec. 30 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., announces that Tim Hansen, CEO of Imaging Diagnostic Systems, was interviewed by WallSt.net, an online financial community website. The interview focused on answering the most frequently asked questions from investors and shareholders.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
The audio interview addressed the CT Laser Mammography Premarket Approval (PMA) submission process to the FDA, international sales, progress in research and development, and the company's recent participation at the Radiological Society of North America (RSNA).
The interview is featured on the WallSt.net website, http://www.wallst.net. A quick registration with the site is required to listen to the 14-minute interview. After registering, enter "IMDS" in the Audio Search box and select the 12/19/2005 interview.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations: Rick Lutz 404-261-1196 lcgroup@mindspring.com
Photo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOImaging Diagnostic Systems, Inc.CONTACT: Rick Lutz for Imaging Diagnostic Systems, Inc., +1-404-261-1196,lcgroup@mindspring.com